Vascul Pharmacol

Circulating soluble IL-6 receptor associates with plaque inflammation but not with atherosclerosis severity and cardiovascular risk.

Edsfeldt A, Gonçalves I, Vigren I, ..., Khan F, Nilsson J

Vascul Pharmacol 152 (-) 107214 [2023-10-00; online 2023-08-25]

Affinity Proteomics Uppsala [Service]

Immune responses against oxidized LDL as possible targets for prevention of atherosclerosis in systemic lupus erythematosus.

Yao Mattisson I, Rattik S, Björkbacka H, ..., Nilsson J, Wigren M

Vascul Pharmacol 140 (-) 106863 [2021-10-00; online 2021-04-15]

Affinity Proteomics Uppsala [Service]